Ritholtz Wealth Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Ritholtz Wealth Management’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-16,716	Closed	-$53K	–	759
2022 Q2	$53K	Buy	16,716 +1,685	+11%	+$6.56K	﹤0.01%	536
2022 Q1	$64K	Buy	+15,031	New	+$65.5K	﹤0.01%	539

Ritholtz Wealth Management's LJPC Position: Q3 2022 in Review

Ritholtz Wealth Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 16,716 shares — an estimated $53K sold.

Ritholtz Wealth Management first reported a position in LJPC in Q1 2022 and held it in 2 quarters. The position peaked at $64K in Q1 2022. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.

Ritholtz Wealth Management reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
Ritholtz Wealth Management sold 16,716 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $53K.
Ritholtz Wealth Management first reported a position in La Jolla Pharmaceutical Company in Q1 2022 and held it in 2 quarters.
Ritholtz Wealth Management's La Jolla Pharmaceutical Company position peaked at $64K in Q1 2022.
0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.

Based on Ritholtz Wealth Management's 13F filing for Q3 2022, filed 19 Oct 2022.